By
Two and a half years after a biological manufacturing company announced its plans to build a facility in Manhattan, there are few answers about when — and if — it’s going to happen, but local and state officials say discussions still are ongoing.
Scorpius, formerly called Scorpion, announced in April 2022 it would construct a $650-million, 500,000-square-foot vaccine and biologic medicine plant on U.S. Highway 24 just east of Manhattan, a facility that would create 500 jobs.
“The state is still at the table,” said Shanna Goodman, executive director of Pottawatomie County Economic Development. “From what I believe, the state is giving them until the end of this year to get their capital in order.”
